Could one stem cell infusion slow Alzheimer's?
Disease control
Not yet recruiting
This study tests whether adding a single infusion of human mesenchymal stem cells to standard antibody therapy can help stabilize memory and thinking in people with mild Alzheimer's or mild cognitive impairment. Ten participants aged 55-90 who are already on an FDA-approved antib…
Phase: PHASE2 • Sponsor: Bernard (Barry) Baumel • Aim: Disease control
Last updated May 01, 2026 16:00 UTC